The partnership brings Nucleus’ advanced carrier and embryo screening to Hawaii’s largest IVF practice
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Nucleus Genomics today announced an IVF+ partnership with the Fertility Institute of Hawaii, bringing its advanced carrier screening and embryo analysis to Hawaii's largest IVF practice.
Through the collaboration, patients will gain deeper genetic insight into their embryos during IVF, including risks tied to cancers, heart disease, and diabetes — conditions that are especially prevalent across the Pacific. It will also expand access to Nucleus for many international patients who travel to Hawaii for fertility care from Japan, Korea, China, Australia, and New Zealand.
